Genetically Engineered Stem Cells Fight Gastroesophageal Cancer
Dr. Saar Gill of the University of Pennsylvania received a $450,000 grant from the DeGregorio Family Foundation to continue research on genetically engineered stem cells to combat gastroesophageal cancer. This builds upon previous work using Chimeric Antigen Receptor (CAR) macrophages to target and destroy cancer cells within solid tumors. The ultimate goal is to develop a long-lasting supply of cancer-fighting cells. […]
CellFE Launches T-REST Kit: Revolutionizing CAR-T Cell Therapy Manufacturing for Breakthrough Cancer Treatments
CellFE, a pioneering biotechnology company, has unveiled its groundbreaking T-REST Resting T Cell Kit, a first-in-class solution designed to revolutionize CAR-T cell therapy manufacturing. This innovative kit aims to enhance the quality and efficacy of CAR-T therapies by optimizing the resting state of T cells, a critical factor in improving patient outcomes. By addressing key […]
Newton Rallies to Save Teen with Leukemia: Join the Stem Cell Donor Drive
In the small town of Newton, Kansas, the community is rallying together for a noble cause—a stem cell donor drive to help save the life of Jonah Huet, a 15-year-old high school student recently diagnosed with leukemia. Jonah, an avid volleyball player and passionate marching band member, urgently needs a stem cell transplant, but no […]
Eterna Therapeutics Investigates ERNA-101 in Cancer Models
Eterna Therapeutics, a preclinical-stage company, announced a research collaboration with MD Anderson Cancer Center to evaluate its lead induced mesenchymal stem cell therapy, ERNA-101, for treating ovarian and breast cancers. ERNA-101, a proprietary allogenic cell therapy, aims to stimulate antitumor immunity. The research will assess ERNA-101’s effects both in vitro and in vivo, with potential future studies exploring […]
Revolutionizing Cancer Treatment: The Impact of Stem Cell Transplants at Community Health Network MD Anderson Cancer Center
At Community Health Network’s MD Anderson Cancer Center, a groundbreaking milestone has been reached with the center’s first stem cell transplant. This significant medical advancement involves the infusion of a patient’s own stem cells, which were harvested, frozen, and reintroduced after a high dose of chemotherapy. The procedure aims to restore the bone marrow and […]
Factor Bioscience and Eterna Therapeutics Partner to Accelerate Advanced Cell Therapies for Cancer, Rare Diseases, and Autoimmune Disorders
In a groundbreaking collaboration that promises to reshape the future of medicine, Factor Bioscience and Eterna Therapeutics have announced an exclusive license agreement to accelerate the development of stem cell-based therapies for oncology, autoimmune disorders, and rare diseases. The agreement is centered around the utilization of Factor’s proprietary induced pluripotent stem cell (iPSC) technologies, which […]
Unlocking the Future of Stem Cell Transplants: New Advances in Hematopoietic Cell Therapies
In the video below, Dr. Michael Grunwald discusses the transformative potential of hematopoietic cell transplantation, also known as stem cell or bone marrow transplantation, particularly for patients with myeloproliferative neoplasms (MPNs). This advanced treatment, though not necessary for all MPN patients, offers a beacon of hope for a select group, leveraging the body’s immune system […]
Unlocking the Power of Stem Cells – How Stem Cell Transplants Offer a Second Chance at Life
In the fight against blood cancer, when conventional treatments like chemotherapy fall short, a stem cell transplant often becomes the last hope for patients. The short video below dives deep into the vital role of stem cells—your body’s raw material with the unique ability to transform into red blood cells, platelets, and the white blood […]
How a College Trip to Israel Led to a Life-Saving Stem Cell Donation
In a heartwarming tale of fate and generosity, a decade-old decision during a college trip to Israel has culminated in a Kansas City woman’s life-saving act. Melissa Kingston, who once joined a birthright trip to Israel during her junior year at KU, never imagined that her participation in a simple stem cell registry would one […]
Senti Bio Receives $8 Million CIRM Grant to Advance Logic-Gated CAR-NK Cell Therapy for AML
Senti Biosciences, Inc., a leader in next-generation cell and gene therapies, has been awarded an $8 million grant by the California Institute for Regenerative Medicine (CIRM). This significant funding will propel the clinical development of SENTI-202, an innovative off-the-shelf CAR-NK cell therapy designed to treat relapsed/refractory hematologic malignancies, including acute myeloid leukemia (AML). Pioneering Cell […]